Intervacc AB

Intervacc AB IVACC

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Intervacc AB shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Intervacc AB
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Intervacc AB
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Intervacc AB dividends.
Year Amount Change
2006 0.0öre
2007 0.0öre
0%
2008 0.0öre
0%
2009 0.0öre
0%
2010 0.0öre
0%
2011 0.0öre
0%
2012 0.0öre
0%
2013 0.0öre
0%
2014 0.0öre
0%
2015 0.0öre
0%
2016 0.0öre
0%
2017 0.0öre
0%
2018 0.0öre
0%
2019 0.0öre
0%
2020 0.0öre
0%
2021 0.0öre
0%
2022 Sign Up Required

Intervacc AB Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 07 July 2022
52 Week Low
0.0% on 07 July 2022
Next Ex-Div-Date Countdown
Sign Up Required

About Intervacc AB

Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The Company operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. It offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.

Sector
Pharmaceuticals & Biotechnology
Country
Sweden
Share Price
kr36.90 (yesterday's closing price)
Shares in Issue
50 million
Market Cap
kr1.9bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found